MUSCAT: Oman has agreed to fast-track the approval of Indian pharma products registered by regulatory agencies in the US, the UK and the EU, the commerce and industry ministry said after the 10th India-Oman Joint Commission Meeting on Wednesday.
“Fast-tracking of approvals for registration of Indian pharmaceutical products already registered by US Food and Drug Administration (US FDA), UK’s Medicines and Healthcare products Regulatory Agency (UKMHRA) and European Medicines Agency (EMA) was agreed to during the deliberations,” a statement released by the ministry said.
“Both sides expressed commitment to facilitate trade and to comprehensively address all issues pertaining to Tariff ot Non-Tariff Barriers.
“Agreement on expeditious conclusion of all Memorandum of Understanding (MoUs) or Agreements under discussion, including on standards and metrology, India-Oman Double Taxation Avoidance Agreement, India-Oman Bilateral Investment Treaty, Invest Oman and Invest India, and Rupay card acceptance in Oman,” the ministry added.
Read More
- Indian expat airlifted to hospital after road accident in Oman
- Truck carrying steel coils triggered deadly 15-vehicle Samail crash: Royal Oman Police
- Global experts to gather in Oman to combat water and climate challenges
- Oman accident: Truck collision causes injuries, traffic congestion on Sultan Thuwaini bin Said Road
- Oman records highest temperature of 46.2°C
His Excellency Qais Al Yousef, Minister of Commerce, Industry and Investment Promotion is currently visiting India as part of the 10th India-Oman Joint Committee Meet.
